Drug
Branched-Chain Amino Acids
Branched-Chain Amino Acids is a pharmaceutical drug with 5 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
1(20%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_4
1
20%
Ph not_applicable
2
40%
Ph phase_2
2
40%
Phase Distribution
0
Early Stage
2
Mid Stage
1
Late Stage
Phase Distribution5 total trials
Phase 2Efficacy & side effects
2(40.0%)
Phase 4Post-market surveillance
1(20.0%)
N/ANon-phased studies
2(40.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
5
all time
Status Distribution
Active(3)
Completed(2)
Detailed Status
Completed2
Not yet recruiting2
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
1
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 22 (40.0%)
Phase 41 (20.0%)
N/A2 (40.0%)
Trials by Status
recruiting120%
completed240%
not_yet_recruiting240%
Recent Activity
1 active trials
Showing 5 of 5
not_yet_recruitingphase_2
Lenvatinib and Pembrolizumab With or Without BCAA in Unresectable HCC
NCT07412054
not_yet_recruitingnot_applicable
Effect of Vitamin D and Branched-chain Amino Acids on Physical Performance and Biomarkers of Muscle Fatigue in Runners
NCT07334054
recruitingnot_applicable
Human Albumin Infusion in Liver Cirrhosis and Overt Hepatic Encephalopathy (HACHE)
NCT06483737
completedphase_2
Amino Acids, Serotonin, and Body Weight Regulation
NCT00343928
completedphase_4
Effects of Proteins in Patients With Cirrhosis and Prior Hepatic Encephalopathy
NCT00955500
Clinical Trials (5)
Showing 5 of 5 trials
NCT07412054Phase 2
Lenvatinib and Pembrolizumab With or Without BCAA in Unresectable HCC
NCT07334054Not Applicable
Effect of Vitamin D and Branched-chain Amino Acids on Physical Performance and Biomarkers of Muscle Fatigue in Runners
NCT06483737Not Applicable
Human Albumin Infusion in Liver Cirrhosis and Overt Hepatic Encephalopathy (HACHE)
NCT00343928Phase 2
Amino Acids, Serotonin, and Body Weight Regulation
NCT00955500Phase 4
Effects of Proteins in Patients With Cirrhosis and Prior Hepatic Encephalopathy
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5